Elanco Animal Health (ELAN) EV to EBIT (2018 - 2026)

Elanco Animal Health has disclosed EV to EBIT across 9 years of filings, most recently posting 47.44 for Q2 2026.

• In Q2 2026, EV to EBIT rose 59.25% year-over-year to 47.44; the TTM figure through Jun 2026 stood at 18.47 (up 107.05% YoY), while the FY2025 annual figure was 19.18, up 626.39% from the prior year.
• EV to EBIT came in at 47.44 for Q2 2026 at Elanco Animal Health, up from 39.6 in the prior quarter.
• In the past five years, EV to EBIT ranged from a high of 101.07 in Q3 2024 to a low of 243.22 in Q4 2025.
• Average EV to EBIT over 5 years is 4.28, with a median of 10.07 recorded in 2022.
• Year-over-year, EV to EBIT jumped 3197.38% in 2024 and sank 2332.28% in 2025.
• Over 5 years, EV to EBIT stood at 10.15 in 2022, then retreated by 7.13% to 10.87 in 2023, then advanced by 8.03% to 10.0 in 2024, then slumped by 2332.28% to 243.22 in 2025, then surged by 119.5% to 47.44 in 2026.
• Per Business Quant data, the three most recent EV to EBIT figures were 47.44 in Q2 2026, 39.6 in Q1 2026, and 243.22 in Q4 2025.